An endoprosthesis, also known as an endoprosthetic device, is used to replace a part of the body that is damaged due to trauma or disease. Endoprosthesis helps in reconstructing bones and joints. Some common applications of endoprosthesis include knee replacement, hip replacement, shoulder replacement and elbow replacement to treat disorders such as osteoarthritis, rheumatoid arthritis and trauma cases.

The global Endoprosthesis Market is estimated to be valued at US$ 21.50 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The endoprosthesis market is expected to witness significant growth owing to rising prevalence of joint disorders across the globe. According to the Arthritis Foundation, around 54 million adults in the US were diagnosed with doctor-diagnosed arthritis in 2018. Similarly, the National Health Interview Survey (NHIS) data analysis indicate that about 24% of adults over the age of 18 have been diagnosed with arthritis. Growing geriatric population, sedentary lifestyles and rising obesity rates are major factors behind the increasing incidence of joint disorders. Moreover, advancements in endoprosthesis technologies such as use of modern biomaterials, 3D printing and robotics are also supporting the market growth. However, high costs associated with endoprosthesis procedures and lack of reimbursement policies in developing regions can hinder the market growth over the forecast period.

SWOT Analysis

Strength: The endoprosthesis market has witnessed strong growth historically due to the strong prevalence of target diseases that require endoprosthesis procedures. The global demand for implants from an aging population presents a substantial business opportunity. Manufacturers in the market have strong distribution networks globally to serve customers worldwide.

Weakness: High costs associated with endoprosthesis procedures can limit the accessible patient population in price sensitive areas. Raw material prices can fluctuate which can squeeze margins for manufacturers.

Opportunity: Emerging markets in Asia Pacific present substantial growth opportunities owing to expanding healthcare infrastructure and growing medical capabilities in the region. Technological advancements in 3D printing and robotics offer potential for product and process innovations.

Threats: Stringent regulatory approvals and recalls can delay new product launches. The threat from alternative treatments poses risks to the overall market size over the long term. Infrastructure barriers exist in developing regions.

Key Takeaways

The global Endoprosthesis Market Size is expected to witness high growth, exhibiting CAGR of 7.5% over the forecast period, due to increasing prevalence of chronic diseases and trauma injuries that require endoprosthetic reconstruction and replacements. The demand for joint replacements and spinal implants is growing significantly worldwide.

Regional analysis

The North American region currently dominates the global market due to major technological advancements and availability of advanced healthcare facilities in the region. However, Asia Pacific is expected to grow at the fastest rate, owing to rising healthcare expenditures, rapidly growing geriatric population, and increase in per capita income in emerging countries of Asia Pacific.

Key players

Key players operating in the endoprosthesis market are Medtronic, Boston Scientific, Abbott Laboratories, Edwards Lifesciences, Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, BD, and Teleflex. Medtronic and Johnson & Johnson dominate the global endoprosthesis devices market.

Get More Insights On This Topic: https://blogger-veritas.blogspot.com/2023/12/knee-endoprosthesis-is-fastest-growing.html